1) Efficacy, effect
1. Essential hypertension
2. Reduces the risk of cardiovascular disease
Patients over 55 years of age who cannot tolerate ACE inhibitors and are at high risk of developing major cardiovascular diseases (past history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or clinical evidence of end-organ damage) Reduced risk of myocardial infarction, stroke, and death from cardiovascular disease in patients with high-risk diabetes for whom there is evidence
2) Usage, dosage
1. Essential hypertension
Adults: As telmisartan, oral administration of 40 mg once daily is recommended, and depending on the patient, 20 mg once daily may be effective. If necessary, the dose can be increased to 80 mg once a day.
This drug has an additional blood pressure lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide.
When increasing the dose, the maximum blood pressure lowering effect occurs 4 to 8 weeks after starting treatment.
2. Reduces the risk of cardiovascular disease
Adults: It is recommended to take 80 mg orally once a day. There is no known risk-reducing effect on cardiovascular morbidity and mortality at doses less than 80 mg. When starting treatment with this drug for the purpose of reducing the risk of cardiovascular disease, monitoring blood pressure is recommended and appropriate adjustment of antihypertensive medications may be required.
○ Patients with liver impairment
It should be administered with caution to patients with mild to moderate hepatic impairment and should not exceed 40 mg once a day.
3) Packaging unit
30 tablets (10 tablets/AluAlu*3)
4) Ingredients, content
Telmisartan Telmisartan 40mg
5) Period of use
36 months from date of manufacture
6 ) Storage method
Airtight container, stored at room temperature (1~30°C)
